Roche Africa

Roche Africa Roche is a global pioneer in pharmaceuticals and diagnostics, focused on advancing science to improve people’s lives.

The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. We partner with national, regional and local stakeholders to identify underlying access issues, then work with local partners on solutions that catalyse exponential change. We take a person-centered approach to health, so that the solutions we design together solve the challenges people face at each step of their health journey: from awareness to diagnosis, to treatment and ongoing care. When working with partners for systems-level change across Africa, we know that we can never lose sight of the individual. Together with our partners, we put people at the heart of everything we do, so that we can all support the whole system and care for the whole person.

Breast cancer in Africa is becoming an economic and societal crisis.More women — including younger women — are being dia...
20/02/2026

Breast cancer in Africa is becoming an economic and societal crisis.

More women — including younger women — are being diagnosed too late.
The impact goes beyond health: it destabilizes families, households, and national development.

The disease already costs African economies an estimated $10.3 billion.

Investing in health is no longer optional. It’s a societal and economic imperative.

So the real question is:
How can investment, technology, and innovation transform breast cancer care?

From digital infrastructure to smarter capital allocation, innovation can remove barriers to care, expand access, and dramatically improve patient outcomes. Technology isn’t just a tool — it’s an enabler and efficiency multiplier.

To explore this further, listen to the latest episode of the Africa Health Ventures podcast, recorded during Africa Tech Festival .

🎧 Featuring Maturin Tchoumi, Thom Renwick, Dr. Kathryn Malherbe, Dr. Carol-Ann Benn, in conversation with Rowena Luk.

🔗 https://rowenaluk.substack.com/p/how-the-fight-against-breast-cancer

Early testing plays a critical role in improving cancer outcomes.When cancer is detected earlier, treatment options expa...
20/02/2026

Early testing plays a critical role in improving cancer outcomes.

When cancer is detected earlier, treatment options expand and survival rates improve, benefiting families and communities alike.

Cervical cancer remains one of the leading causes of cancer death among women in sub-Saharan Africa.Early testing and ac...
19/02/2026

Cervical cancer remains one of the leading causes of cancer death among women in sub-Saharan Africa.

Early testing and access to diagnostics play a critical role in improving outcomes and saving lives.

Following World Cancer Day, attention turns to closing the cancer care gap across sub-Saharan Africa.Cancer outcomes imp...
18/02/2026

Following World Cancer Day, attention turns to closing the cancer care gap across sub-Saharan Africa.

Cancer outcomes improve when disease is detected early. Strengthening access to diagnostics supports earlier diagnosis, stronger health systems and progress toward Universal Health Coverage.

Roche Diagnostics partners with stakeholders across Africa to support sustainable cancer care pathways.

04/02/2026

“If I could do it, you can do it,” says Denise, a two-time breast cancer survivor in Africa.

When she was diagnosed, Denise felt the same shock and fear experienced by thousands of women each year. With the support of her family, she moved from being labelled “the lady with cancer” to becoming a source of strength for others, helping women take their first steps towards care and hope.

On , we are reminded that while every cancer journey is deeply personal, our shared goal is clear: where you live should never determine your chance of survival. Yet in parts of Africa, survival rates can be as low as 50%, compared with 90% in high-income countries.

At Roche, we believe cancer care must be people-centred — focused on the person, not just the disease. That means investing in breakthrough science, prioritising healthcare globally, and working together to remove the barriers that prevent patients from accessing the care they need.

Through the African Breast Cancer Ambition (ABCA) and partnerships across countries and sectors, we are committed to helping change the story of breast cancer.

Let’s do it together.

Read more about Denise’s journey and our work in Africa here: https://africa.roche.com/stories/why-investing-in-health-matters-for-breast-cancer-patients

can affect any woman, but a simple test can reduce your risk. Outside laboratories and clinics, self-collection can ...
30/01/2026

can affect any woman, but a simple test can reduce your risk.

Outside laboratories and clinics, self-collection can help overcome the cultural, social and geographic barriers that keep many women from seeking care.

When testing can happen privately and safely, more women can enter the screening pathway with dignity and confidence.

To find out more about beating cervical cancer, speak to your healthcare professional today.

27/01/2026

Cervical cancer is the leading cancer for women aged 15 to 44 years in the prime of their lives.

To screen 70 percent of women by age 35, adopting high-throughput laboratory capacity enables the processing of large volumes accurately and consistently, and scale is what allows national screening goals to be met.

Every woman in Africa deserves a chance at a healthy life.

Speak to your healthcare provider and get tested regularly to reduce your risk of cervical cancer.

على إثر الظروف المناخية القاسية التي شهدتها تونس وليبيا مؤخرًا، نعبّر عن تضامننا مع السكان المتضررين من هذه الأحداث. نتق...
21/01/2026

على إثر الظروف المناخية القاسية التي شهدتها تونس وليبيا مؤخرًا، نعبّر عن تضامننا مع السكان المتضررين من هذه الأحداث.
نتقدم بتعازينا الصادقة لعائلات الضحايا، ونتضامن مع جميع من تأثروا بهذه الكوارث الطبيعية.
في هذه الظروف الصعبة، نعبّر عن دعمنا للمجتمعات المتضررة، ونأمل بعودة ظروف مناخية أكثر اعتدالًا في تونس وليبيا.
Face aux événements climatiques extrêmes qui ont récemment touché la Tunisie et la Libye, nous souhaitons exprimer notre solidarité avec les populations affectées.
Nos pensées vont aux victimes, à leurs familles et à toutes les personnes impactées par ces catastrophes naturelles.
En ces moments difficiles, nous adressons notre soutien aux communautés touchées et formulons l’espoir d’un retour à des conditions climatiques plus clémentes en Tunisie et en Libye.

Why does a woman in Africa diagnosed with have only a 50 per cent chance of surviving five years, while in high-income...
21/01/2026

Why does a woman in Africa diagnosed with have only a 50 per cent chance of surviving five years, while in high-income countries the chance is 90 per cent? For us, this is unacceptable, and we remain committed to our bold ambition to radically improve breast cancer survival rates in Africa.

Dr. Zainab Shinkafi Bagudu, President-elect of the UICC - Union for International Cancer Control 2024-2026 and a member of the , has the same bold ambition. Her new article, published by Africa.com, highlights how inadequate breast cancer care is costing African women their lives. It also shows that, according to a study by the WifOR Institute in seven African countries, early detection and access to effective treatments can save lives, improve quality of life, and deliver measurable economic benefits to communities.

“It is no exaggeration to say that the future of Africa depends on the health of women,” she says, and we couldn’t agree more. We are advancing through multi-stakeholder collaboration to help women on our continent to beat breast cancer through early diagnosis and better treatment. Let’s work together to build a strategy that combines political leadership, financial investment, smart partnerships, and community-driven solutions. You can read the article here: https://africa.com/turning-the-tide-on-breast-cancer-in-africa/

20/01/2026

At the G20 Social Summit, South Africa’s National Department of Health confirmed that the launch of the cervical cancer elimination strategy is imminent.

This provides the country with a clear, structured path to the 90-70-90 WHO targets and is a turning point for women’s health, as it formally acknowledges the value of protecting South African women against the most prevalent healthcare threats.

90-70-90 means:

● vaccination: 90% of girls fully vaccinated with the HPV vaccine by the age of 15;
● screening: 70% of women screened using a high-performance test by the age of 35, and again by the age of 45;
● treatment: 90% of women with pre-cancer treated and 90% of women with invasive cancer managed.

When cervical cancer is identified early, the five-year relative survival rate reaches 91 percent.

Once the disease has spread significantly, it drops to 19 percent.

Expanding access to high-quality, high-performance HPV (Human Papillomavirus) testing is one of the strongest levers available to protect women’s lives in this context.

Nous sommes ravis d’annoncer la nomination de Galais en tant que Directeur Général de Roche Tunisie & Libye.Fort de plu...
09/12/2025

Nous sommes ravis d’annoncer la nomination de Galais en tant que Directeur Général de Roche Tunisie & Libye.
Fort de plus de 18 ans d’expérience au sein du groupe Roche, Matthieu a dirigé plusieurs projets stratégiques en Afrique et occupé des fonctions clés en transformation digitale et pilotage international. Plus récemment, il a dirigé la région Afrique Centrale, couvrant à la fois les activités de Roche Pharma et Diagnostics. Son leadership collaboratif et son engagement envers l’accès à l’innovation seront des atouts majeurs pour accompagner l’évolution des systèmes de santé en Tunisie et en Libye.

Dans ses nouvelles responsabilités, Matthieu œuvrera à renforcer les partenariats institutionnels, à accélérer l’accès aux solutions de santé innovantes et à contribuer à un impact concret pour les patients.

Nous lui souhaitons plein succès dans cette nouvelle mission !

Félicitations, Matthieu !

We are pleased to announce the appointment of Matthieu Galais as the new General Manager of Roche Tunisia & Libya.
With more than 18 years of experience at Roche, Matthieu has led strategic initiatives across Africa and held key roles in digital transformation and global portfolio management. Most recently, he led the Central Africa region, with responsibilities spanning across both Roche Pharma and Diagnostics Divisions. His collaborative leadership and commitment to expanding access to innovation will support the continued strengthening of healthcare systems in Tunisia and Libya.

In his new role, he will focus on advancing medical innovation, building strong institutional partnerships, and driving meaningful impact for patients.
We wish him great success in this new chapter.

Congratulations, Matthieu!

This week, Roche Diagnostics held a media briefing to launch the Accu-Chek SmartGuide® continuous glucose monitoring (CG...
07/11/2025

This week, Roche Diagnostics held a media briefing to launch the Accu-Chek SmartGuide® continuous glucose monitoring (CGM) solution – the first AI-enabled CGM system available in South Africa.

Diabetes is one of today’s most urgent healthcare challenges. As of 2024, 4.2 million people in South Africa are living with the condition.

The Accu-Chek SmartGuide® solution provides up to 14 days of accurate real-time glucose values for adults living with diabetes.

Artificial intelligence (AI)-enabled algorithms can predict glucose levels up to two hours ahead and overnight, empowering users to take action before a glucose excursion occurs.

By helping people take action before their glucose levels move out of range, SmartGuide provides more proactive, data-driven diabetes care.

Address

Building E, Hertford Office Park, 90 Bekker Road
Midrand
1686

Website

Alerts

Be the first to know and let us send you an email when Roche Africa posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category